Catalyst Wire Dossier Catalyst Wire Dossier

HuZAF

humanized anti-Interferon-γ monoclonal antibody · Facet Biotech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HuZAF, covering 2012-03-13 to 2012-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease [Phase 2]

See pricing